Patel Samir Rashmikant 4
4 · Akari Therapeutics Plc · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Patel Samir Rashmikant
Director
Transactions
- Award
Ordinary Shares, par value $0.0001 per share
2024-12-02$0.00/sh+419,286,000$503,143→ 5,235,403,500 total(indirect: By LLC) - Award
Stock Option (Right to Buy)
2024-11-30+162,604,000→ 162,604,000 totalExercise: $0.00From: 2024-11-30Exp: 2034-11-30→ Ordinary Shares, par value $0.0001 per share (162,604,000 underlying) - Award
Warrants (Right to Buy)
2024-12-02$0.00/sh+419,286,000$503,143→ 419,286,000 total(indirect: By LLC)Exercise: $0.00From: 2024-12-02Exp: 2027-12-02→ Ordinary Shares, par value $0.0001 per share (419,286,000 underlying)
Holdings
- 91,396,000
Ordinary Shares, par value $0.0001 per share
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
- [F2]On December 2, 2024, the Reporting Person acquired 419,286,000 Ordinary Shares and accompanying warrants to purchase up to 419,286,000 Ordinary Shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of November 13, 2024. The combined purchase price was $0.001193 per Ordinary Share and accompanying warrant.
- [F3]The stock options have an exercise price of $0.000615 per Ordinary Share.
- [F4]The warrants have an exercise price of $0.001130 per Ordinary Share.